COVID-19 and essential pregnant worker policies.
Published in The Lancet. Infectious diseases
RT-PCR for SARS-CoV-2: quantitative versus qualitative.
Published in The Lancet. Infectious diseases
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-base...
...Published in The Lancet. Infectious diseases
As the COVID-19 pandemic continues to unfold, the infection-fatality risk (ie, risk of death among all infected individuals including those with asymptomatic and mild infections) is crucial for gauging the burden of death due to COVID-19 in the coming months or years. Here, we estimate the infection-fatality risk of severe acute respiratory syndrom...
Good news from WHO on prevention of peripartum hepatitis B transmission.
Published in The Lancet. Infectious diseases
Re-examining the notion of irrational antimicrobial prescribing in LMICs.
Published in The Lancet. Infectious diseases
Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silent.
Published in The Lancet. Infectious diseases
Human T-cell lymphotropic virus type-1 (HTLV-1) has a large global burden and in some key communities, such as Indigenous Australians living in remote areas, greater than 45% of people are infected. Despite HTLV-1 causing serious malignancy and myelopathic paraparesis, and a significant association with a range of inflammatory comorbidities and sec...
SARS-CoV-2 and the human-animal interface: outbreaks on mink farms.
Published in The Lancet. Infectious diseases
Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B vir...
Published in The Lancet. Infectious diseases
To eliminate mother-to-child transmission (MTCT) of hepatitis B virus (HBV), peripartum antiviral prophylaxis might be required for pregnant women infected with HBV who have a high risk of MTCT despite infant immunoprophylaxis. We aimed to determine the efficacy and safety of peripartum antiviral prophylaxis to inform the 2020 WHO guidelines. In th...
Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic r...
...Published in The Lancet. Infectious diseases
Prevention of mother-to-child transmission (MTCT) of hepatitis B virus (HBV) involves neonatal immunoprophylaxis, with a birth dose of hepatitis B vaccine and immune globulin, and provision of peripartum antiviral prophylaxis in highly viraemic women. However, access to assays to quantify HBV DNA levels remains inadequate in resource-poor settings....
The place for remdesivir in COVID-19 treatment.
Published in The Lancet. Infectious diseases
